2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

• Published in: Journal of the American College of Cardiology Vol. 73; no. 24; pp. e285 - e350
• Main Authors: Grundy, Scott M, Stone, Neil J, Bailey, Alison L, Beam, Craig, Birtcher, Kim K, Blumenthal, Roger S, Braun, Lynne T, de Ferranti, Sarah, Faiella-Tommasino, Joseph, Forman, Daniel E, Goldberg, Ronald, Heidenreich, Paul A, Hlatky, Mark A, Jones, Daniel W, Lloyd-Jones, Donald, Lopez-Pajares, Nuria, Ndumele, Chiadi E, Orringer, Carl E, Peralta, Carmen A, Saseen, Joseph J, Smith, Jr, Sidney C, Sperling, Laurence, Virani, Salim S, Yeboah, Joseph
• Format: Journal Article
• Language: English
• Published: United States Elsevier Limited 25.06.2019
• Subjects: American Heart Association; Anticholesteremic Agents - pharmacology; Biomarkers - blood; Cardiology; Cardiology - methods; Cardiology - standards; Cardiovascular Diseases - prevention & control; Cardiovascular Diseases - psychology; Cholesterol; Clinical practice guidelines; Disease management; Ezetimibe - pharmacology; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacology; Hypercholesterolemia - blood; Hypercholesterolemia - diagnosis; Hypercholesterolemia - epidemiology; Hypercholesterolemia - therapy; Medication Therapy Management - standards; Patient compliance; Proliferating cell nuclear antigen; Proprotein Convertase 9 - antagonists & inhibitors; Risk Assessment - methods; Risk Reduction Behavior; United States; United States; ACC/AHA Clinical Practice Guidelines; cardiovascular disease; patient compliance; risk assessment; lipids; drug therapy; risk reduction discussion; secondary prevention; hydroxymethylglutaryl-CoA reductase inhibitors/statins; biomarkers; proprotein convertase subtilisin/kexin type 9 inhibitor (PCSK9) inhibitors; diabetes mellitus; hypercholesterolemia; pharmacological; Guidelines; LDL-cholesterol; coronary artery calcium score; ezetimibe; primary prevention; cholesterol; risk treatment discussion
• ISSN: 0735-1097; 1558-3597
• DOI: 10.1016/j.jacc.2018.11.003

Since 1980, the American College of Cardiology (ACC) and American Heart Association (AHA) have translated scientific evidence into clinical practice guidelines with recommendations to improve cardiovascular health. These guidelines, which are based on systematic methods to evaluate and classify evidence, provide a foundation for the delivery of quality cardiovascular care. The ACC and AHA sponsor the development and publication of clinical practice guidelines without commercial support, and members volunteer their time to the writing and review efforts.